Zuellig issue likely to sort out in Sept.

Published: 2001-09-21 07:00:00

Updated: 2001-09-21 07:00:00

The Zuellig issue seems to be resolved very soon, judging by the fact that the Struggle Committee for Zuellig Issue ultimately asked Zuellig for the business terms and conditions instead of number of business associated company in controversy.

The related business community assumed that a prot...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK